+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

Hyperimmune Globulin Injection Market - Global Forecast to 2030 - Product Thumbnail Image

Hyperimmune Globulin Injection Market - Global Forecast to 2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
From
Plasma-Derived Medicines - Global Strategic Business Report - Product Thumbnail Image

Plasma-Derived Medicines - Global Strategic Business Report

  • Report
  • September 2025
  • 391 Pages
  • Global
From
From
From
From
Angioedema Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Angioedema Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Plasma Therapy Market Report 2025 - Product Thumbnail Image

Plasma Therapy Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Convalescent Plasma Therapy Market Report 2025 - Product Thumbnail Image

Convalescent Plasma Therapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Intravenous Immunoglobulin Market - Global Forecast 2025-2030 - Product Thumbnail Image

Intravenous Immunoglobulin Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 191 Pages
  • Global
From
Loading Indicator